Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction

Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):33-40. doi: 10.1097/01.hjr.0000116824.84388.a2.

Abstract

Background: The summarized importance of haemostatic and metabolic variables (insulin, lipids including lipoprotein (a) [Lp(a)] and leptin) in predicting first myocardial infarction, as well as possible interactions among these variables, have not been reported.

Design: A prospective case-control study nested within the Northern Sweden Health and Disease Cohort.

Methods: Sixty-two men diagnosed with a first myocardial infarction were sex- and age-matched with 124 controls. Conditional logistic regression was conducted including established risk factors, plasma levels of plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) mass concentration, von Willebrand factor, insulin, proinsulin, specific insulin, apolipoprotein A-I (apo A-I), Lp(a), and leptin. Interaction analysis was also performed for tPA, apo A-I, Lp(a), leptin and proinsulin.

Results: Smoking, low plasma levels of apo A-I and high plasma levels of cholesterol, Lp(a), tPA, PAI-1, proinsulin and leptin were associated with myocardial infarction in univariate conditional logistic regression analysis. High tPA [odds ratio (OR), 21.3; 95% confidence interval (CI), 2.04-222] and Lp(a) (OR, 7.21; 95% CI, 1.31-39.8) and low apo A-I (OR, 0.15; 95% CI, 0.02-0.93) remained significant risk determinants in multivariate analysis with smoking habits, body mass index, hypertension, cholesterol, and diabetes included as covariates. There were non-significant synergic interactions between high Lp(a) and leptin and tPA, respectively, and between high Lp(a) and low apo A-I.

Conclusion: Plasma levels of tPA, Lp(a), and apo A-I are independently associated with subsequent development of a first myocardial infarction in men.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins B / blood
  • Biomarkers / blood
  • Blood Pressure / physiology
  • Body Mass Index
  • Case-Control Studies
  • Diastole / physiology
  • Female
  • Fibrinolysis / physiology*
  • Humans
  • Leptin / blood*
  • Lipoprotein(a) / blood
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction / blood*
  • Myocardial Infarction / physiopathology*
  • Plasminogen Activator Inhibitor 1 / blood
  • Prospective Studies
  • Statistics as Topic
  • Sweden
  • Systole / physiology
  • Tissue Plasminogen Activator / blood
  • von Willebrand Factor / metabolism

Substances

  • Apolipoproteins B
  • Biomarkers
  • Leptin
  • Lipoprotein(a)
  • Lipoproteins
  • Plasminogen Activator Inhibitor 1
  • von Willebrand Factor
  • Tissue Plasminogen Activator